Subcutaneous Continuous Versus Interrupted Sutures During Cesarean Section.
NCT ID: NCT04220294
Last Updated: 2023-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1238 participants
INTERVENTIONAL
2020-01-10
2022-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Subcutaneous Tissue Closure on Wound Complications
NCT03354078
Surgical Site Infection Rates in Obese Patients After Cesarean Delivery
NCT01713751
Wound Infection in Obese Women After Cesarean Delivery
NCT01679379
The Influence of Endometrial Suturing on the Risk of Uterine Scar Defect
NCT03851003
Suture Material for Closure of Hysterotomy
NCT03026647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Interrupted sutures.
2. Continuous sutures. Information regarding medical and obstetric history will be collected for each patient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interrupted sutures
Subcutaneous tissue closure by interrupted sutures.
Subcutaneous tissue closure
Subcutaneous tissue closure with 2-0 vicryl suture.
Continuous sutures
Subcutaneous tissue closure by continuous sutures.
Subcutaneous tissue closure
Subcutaneous tissue closure with 2-0 vicryl suture.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Subcutaneous tissue closure
Subcutaneous tissue closure with 2-0 vicryl suture.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subcutaneous tissue layer\>2 centimeter according to ultrasound.
Exclusion Criteria
* Fever during the 48 hours prior to surgery.
* Antibiotic treatment during the 48 hours prior to surgery.
* Inability to give informed consent.
* Preterm delivery (\< 37 weeks' gestation).
* Fetal death.
* Known fetal anomalies or placental abnormalities.
* Immunosuppressive conditions.
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rambam Health Care Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ROY LAUTERBACH MD
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roy Lauterbach, MD
Role: PRINCIPAL_INVESTIGATOR
Rambam Healthcare Campus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rambam healthcare campus
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0621-19-RMB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.